
Neuronetics Secures $18M in Public Offering to Fuel Growth and Innovation in Neurohealth
Summary Neuronetics has priced an $18 million underwritten public offering of common stock to bolster its growth strategy. The funds will support sales and marketing efforts, research and development, potential acquisitions, and other corporate purposes. […]